RecruitingNCT05881226
Application of Biomarkers in Neurological Diseases
Sponsor
Yi Yang
Enrollment
3,000 participants
Start Date
Jun 5, 2023
Study Type
OBSERVATIONAL
Conditions
Summary
To explore the predictive and diagnostic role of biomarkers in patients with neurological diseases.
Eligibility
Inclusion Criteria2
- Patients with neurological diseases;
- Subjects or legal agents agree to participate in the study and sign the informed consent.
Exclusion Criteria3
- Participating in other clinical investigators;
- Unwilling to be followed up or poor treatment compliance;
- Other conditions considered unsuitable for inclusion by the researchers.
Interested in this trial?
Get notified about updates and connect with the research team.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT05881226
Related Trials
Cerebral Small Vessel Disease Progression Dependent on Stroke Type
NCT076111361 location
Epigenetic Biomarkers in the Saliva for the Diagnosis of Squamous Cells Carcinoma of the Oral Cavity
NCT057911491 location
AI-assisted CT for Risk Stratification in Coronary Artery Disease (ACTION)
NCT075776091 location
RUSS-AGE: Creating of a Biological Age Calculator and Study of Aging Phenotypes in the Russian Population
NCT075743591 location
Pleural Effusion Biomarkers in Lung Adenocarcinoma Patients
NCT070127591 location